| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2101086 | SI-B001双特异性抗体注射液 | izalontamab | Injection | Biological Products(1) | New Drug Application | 2021-05-19 | Sichuan Baili Pharmaceutical Co Ltd | view | |||
| CXSL2400182 | SI-B001双特异性抗体注射液 | izalontamab | Injection | Biological Products(1) | New Drug Application | 2024-03-14 | Sichuan Baili Pharmaceutical Co Ltd;Baili-Bio (Chengdu) Pharmaceutical Co Ltd | view | |||
| CXSL2101233 | SI-B001双特异性抗体注射液 | izalontamab | Injection | Biological Products(1) | New Drug Application | 2021-08-03 | Sichuan Baili Pharmaceutical Co Ltd | view | |||
| CXSB2300035 | SI-B001双特异性抗体注射液 | izalontamab | Injection | Biological Products(1) | Supplementary Application | 2023-04-15 | Sichuan Baili Pharmaceutical Co Ltd;Baili-Bio (Chengdu) Pharmaceutical Co Ltd | view | |||
| CXSL2101084 | SI-B001双特异性抗体注射液 | izalontamab | Injection | Biological Products(1) | New Drug Application | 2021-05-18 | Sichuan Baili Pharmaceutical Co Ltd | view | |||
| CXSL2101461 | SI-B001双特异性抗体注射液 | izalontamab | Injection | Biological Products(1) | New Drug Application | 2021-12-06 | Sichuan Baili Pharmaceutical Co Ltd | view | |||
| CXSL2101232 | SI-B001双特异性抗体注射液 | izalontamab | Injection | Biological Products(1) | New Drug Application | 2021-08-03 | Sichuan Baili Pharmaceutical Co Ltd | view | |||
| CXSL2101511 | SI-B001双特异性抗体注射液 | izalontamab | Injection | Biological Products(1) | New Drug Application | 2021-12-27 | Sichuan Baili Pharmaceutical Co Ltd | view | |||
| CXSL2101085 | SI-B001双特异性抗体注射液 | izalontamab | Injection | Biological Products(1) | New Drug Application | 2021-05-20 | Sichuan Baili Pharmaceutical Co Ltd | view | |||
| CXSL2101083 | SI-B001双特异性抗体注射液 | izalontamab | Injection | Biological Products(1) | New Drug Application | 2021-05-19 | Sichuan Baili Pharmaceutical Co Ltd | view | |||
| CXSB2400051 | SI-B001双特异性抗体注射液 | izalontamab | Injection | Biological Products(1) | Supplementary Application | 2024-05-29 | Sichuan Baili Pharmaceutical Co Ltd;Baili-Bio (Chengdu) Pharmaceutical Co Ltd | view | |||
| CXSL1900089 | SI-B001双特异性抗体注射液 | izalontamab | Injection | Biological Products(1) | New Drug Application | 2019-08-17 | 四川百利药业有限责任公司 | Sichuan Baili Pharmaceutical Co Ltd | In Review | 2019-08-16 | view |